Brief: Nrx Pharmaceuticals Appoints Stephen Willard As CEO
13/07/2022 13:23
July 13 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF STEPHEN
WILLARD, CHIEF EXECUTIVE OFFICER AND DIRECTOR
* NRX PHARMACEUTICALS - INTERIM CEO, ROBERT BESTHOF, WILL
CONTINUE
TO SUPPORT CO AND RETURN TO ROLES AS HEAD OF OPERATIONS & CHIEF
COMMERCIAL OFFICER
Source text for Eikon: ID:nPn3sWDQka
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview